✦ LIBER ✦

6. Novel enzyme replacement therapy for Gaucher disease: On-going phase III clinical trial with recombinant human glucocerebrosidase expressed in plant cells

✍ Scribed by David Aviezer; Einat Almon-Brill; Yossef Shaaltiel; Gad Galili; Raul Chertkoff; Sharon Hashmueli; Eithan Galun; Ari Zimran

Book ID: 116988191
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 44 KB
Volume: 93
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2007.10.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8. Novel enzyme replacement therapy for

8. Novel enzyme replacement therapy for Gaucher disease: Ongoing Phase III clinical trial with recombinant human glucocerebrosidase expressed in plant cells

✍ David Aviezer; Einat Almon-Brill; Yoseph Shaaltiel; Gad Galili; Raul Chertkoff; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Pivotal trial with plant cell-expressed

Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease

✍ Zimran, A.; Brill-Almon, E.; Chertkoff, R.; Petakov, M.; Blanco-Favela, F.; Muno 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 289 KB

9. Novel enzyme replacement therapy for

9. Novel enzyme replacement therapy for Gaucher disease: Phase III pivotal clinical trial with plant cell expressed recombinantglucocerebrosidase (prGCD) – taliglucerase alpha

✍ David Aviezer; Einat Almon-Brill; Yoseph Shaaltiel; Raul Chertkoff; Sharon Hashm 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB